Medicis buys LipoSonix
This article was originally published in The Gray Sheet
Executive Summary
Privately held LipoSonix, which is developing a non-invasive, ultrasound technology-based system for body contouring as an alternative to invasive liposuction for fat reduction, is acquired by aesthetic dermal filler and pharmaceutical firm Medicis for $150 million on July 1. The deal calls for Medicis to pay up to an additional $150 million upon FDA approval of the technology "and if various commercial milestones are achieved on a worldwide basis," Medicis says. The firm anticipates FDA market go-ahead by 2011
You may also be interested in...
Solta Buys LipoSonix Noninvasive Fat Ablation Tech To Expand Aesthetics Biz
Aesthetics device firm Solta Medical is moving beyond skin aesthetics to the noninvasive fat-removal space with its acquisition of Medicis Pharmaceutical’s LipoSonix technology business unit.
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.